Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Completion Of A Non -Exclusive Discount Agreement According To § 130A Paragraph 8 Sgb V On The Active Ingredient Vedolizumab, Atc L04Aa33 For The Period 01.07.2025 - 30.06.2027
Deadline - May 05, 2027
GT reference number - 109147123
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 109147123
Document Type - Tender Notices
Description - Description: Scope of procurementShort descriptionSection 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to include framework discount contracts for the drugs to be issued at the expense of the statutory health insurance companies. With regard to the relevant legal regulations on the awarding of public orders, a regular process of active ingredient, formal award procedures takes place according to the regulations of the 4th part of the GWB through DAK health. For medicines to be named by the bidder in Appendix 2 to the contract to the above. Vedolizumab active ingredient, ATC L04AA33, intends to conclude the DAK health until the entry into force of new
Gt Ref Id - 109147123
Deadline - May 05, 2027
Similar Tenders :
|
Summary:
|
|
Summary:
|
Join to access thousands of business opportunities
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database
